The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Vasopressin V 2 -Receptor Blockade With Tolvaptan in Patients With Chronic Heart Failure: Results From a Double-Blind, Randomized Trial
Abstract
Background— In this study, we evaluated the effects of tolvaptan (OPC-41061), a novel, oral, nonpeptide vasopressin V 2 -receptor antagonist in patients with chronic heart failure (CHF). Methods and Results— This was a double-blind study investigating the effects of three doses of tolvaptan and placebo in patients with CHF. After a run-in period, 254 patients were randomly assigned to placebo (n=63) or tolvaptan [30 mg (n=64), 45 mg (n=64), or 60 mg (n=63)] once daily for 25 days. Patients were not fluid-restricted and were maintained on stable doses of furosemide. At day 1, when compared with baseline, a decrease in body weight of −0.79±0.99, −0.96±0.93, and −0.84±0.02 kg was observed in the 30-, 45-, and 60-mg tolvaptan groups, respectively, and a body weight increase of +0.32±0.46 kg in the placebo group ( P <0.001 for all treatment groups versus placebo). Although the initial decrease in body weight was maintained during the study, no further reduction was observed beyond the first day. An increase in urine volume was observed with tolvaptan when compared with placebo (3.9±0.6, 4.2±0.9, 4.6±0.4, and 2.3±0.2 L/24 hours at day 1 for 30-, 45-, and 60-mg tolvaptan groups, and placebo, respectively; P <0.001). A decrease in edema and a normalization of serum sodium in patients with hyponatremia were observed in the tolvaptan group but not in the placebo group. No significant changes in heart rate, blood pressure, serum potassium, or renal function were observed. Conclusions— In patients with CHF, tolvaptan was well tolerated; it reduced body weight and edema and normalized serum sodium in the hyponatremic patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cuffe, M. S. (2002) · JAMA · doi:10.1001/jama.287.12.1541 · Cited by 1,175
Increased plasma arginine vasopressin levels in patients with congestive heart failure
Goldsmith, S. R., Francis, G. S., Cowley, A. W., Barry Levine, T., & Cohn, J. N. (1983) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(83)80040-0 · Cited by 484
Diuretic Therapy for Hypertension and the Risk of Primary Cardiac Arrest
Siscovick, D. S., Raghunathan, T. E., Psaty, B. M., Koepsell, T. D., Wicklund, K. G., Lin, X., Cobb, L., Rautaharju, P. M., Copass, M. K., & Wagner, E. H. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406303302603 · Cited by 434
Diuretics and Risk of Arrhythmic Death in Patients With Left Ventricular Dysfunction
Cooper, H. A., Dries, D. L., Davis, C. E., Shen, Y. L., & Domanski, M. J. (1999) · Circulation · doi:10.1161/01.cir.100.12.1311 · Cited by 377
Yamamura, Y., Nakamura, S., Itoh, S., Hirano, T., Onogawa, T., Yamashita, T., Yamada, Y., Tsujimae, K., Aoyama, M., Kotosai, K., et al. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37873-5 · Cited by 337
(1985) · The American Journal of Cardiology · doi:10.1016/0002-9149(85)90290-5 · Cited by 246
Characterization of the precipitants of hospitalization for heart failure decompensation
Bennett, S., Huster, G., Baker, S., Milgrom, L., Kirchgassner, A., Birt, J., & Pressler, M. (1998) · American Journal of Critical Care · doi:10.4037/ajcc1998.7.3.168 · Cited by 240
Kearney, M. T., Fox, K. A. A., Lee, A. J., Prescott, R. J., Shah, A. M., Batin, P. D., Baig, W., Lindsay, S., Callahan, T. S., Shell, W. E., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02490-7 · Cited by 220
Ikram, H., Chan, W., Espiner, E. A., & Nicholls, M. G. (1980) · Clinical Science · doi:10.1042/cs0590443 · Cited by 174
Hirano, T., Yamamura, Y., Nakamura, S., Onogawa, T., & Mori, T. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35289-9 · Cited by 120
Cited by
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
Hunt, S. A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.022 · Cited by 4,154
2005 WRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192065 · Cited by 3,720
WRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.167586 · Cited by 2,251
Konstam, M. A. (2007) · JAMA · doi:10.1001/jama.297.12.1319 · Cited by 1,628
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.013 · Cited by 1,374
Metadata
- Authors
- Gheorghiade, M., Niazi, I., Ouyang, J., Czerwiec, F., Kambayashi, J.-I., Zampino, M., & Orlandi, C.
- Venue
- Circulation
- Published
- 2003-06-03
- Volume
- 107
- Issue
- 21
- Pages
- 2690-2696
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2059717547
- Cited by
- 428
- References
- 12
- FWCI
- 22.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vasopressin V 2 -Receptor Blockade With Tolvaptan in Patients With Chronic Heart Failure: Results From a Double-Blind, Randomized Trial. https://app.cochat.ai/papers/10.1161/01.cir.0000070422.41439.04
- The paper
- Gheorghiade, M., Niazi, I., Ouyang, J., Czerwiec, F., Kambayashi, J.-I., Zampino, M., & Orlandi, C. (2003). Vasopressin V 2 -Receptor Blockade With Tolvaptan in Patients With Chronic Heart Failure: Results From a Double-Blind, Randomized Trial. Circulation. https://doi.org/10.1161/01.cir.0000070422.41439.04
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.